Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Amphioxus Cell Technologies Inc
Profile last edited on: 1/5/07      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1995
First Award
2002
Latest Award
2002
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

11222 Richmond Avenue Suite 180
Houston, TX 77082
   (281) 679-7900
   info@amphioxus.com
   www.amphioxus.com
Location: Single
Congr. District: 09
County: Harris

Public Profile

Amphioxus Cell Technologies Inc. (ACT) is a biotechnology company that makes liver biology available to the medical marketplace. ACT specializes in cultured human liver cell lines with products for drug discovery, toxicology, protein production and artificial liver support. The company is positioning its products as an industry standard for drug discovery and in vitro toxicology, and has a prominent position in functional genomics through its collaboration with Incyte Genomics Inc. (Nasdaq:INCY).

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$235,000
Phase II Dollars
$0
Total Awarded
$235,000

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2002 1 NIH $235,000
Project Title: High Throughput Liver Toxicity Screening

Key People / Management

  James H Kelly -- President

Company News

There are no news available.